Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Upadacitinib may effectively treat resistant lichen planopilaris.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

A microemulsion with Carthamus tinctorius extract effectively inhibits 5α-reductase and improves skin and hair follicle delivery.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

L-cystine, D-pantothenat, and miliacin together significantly boost keratinocyte growth and metabolism.

Reducing gefitinib dosage improved hair loss, but scarring remained.

The hydrogel with neem and tridax extracts effectively treats seborrheic dermatitis.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

A man with a rare skin condition and a new gene mutation developed high calcium levels due to his treatment.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Niosomes can effectively deliver cetirizine topically for treating alopecia.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.